Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Effect on Clock Genes in T2D
NCT02783196Unknown
- Sponsor
- Tel Aviv University
- Start
- Jul 2016
- Primary completion
- Dec 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide First with Placebo First (2 arms). Primary endpoints: Change in the oscillation of Clock Gene mRNA expression in white blood cells at 40 days, Change in AMPK mRNA expression in white blood cells at 40 days and 2 more. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02783196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783196.